|9 Months Ended|
Jul. 02, 2022
|Share-based Payment Arrangement [Abstract]|
Note 14—Equity-Based Compensation
2020 Omnibus Incentive Plan
In October 2020, we adopted the Leslie’s, Inc. 2020 Omnibus Incentive Plan (the “Plan”). The Plan provides for the grant of awards such as stock options to purchase Leslie’s common stock (each, a “Stock Option”) and restricted stock units (“RSUs”) which may settle in Leslie’s, Inc. common stock to our directors, executives and eligible employees of the Company. Stock Options granted under the Plan generally expire ten years from the date of grant and consist of Stock Options that vest upon the satisfaction of time-based requirements (“Service Stock Option”) and performance-based Stock Options that vest upon satisfaction of a performance-based requirement (“Performance Stock Options”). RSUs consist of grants that vest ratably upon the satisfaction of time-based requirements (“Service RSU”) and performance-based RSUs that vest upon satisfaction of performance-based requirements (“Performance RSU”). In each case, vesting of the Company’s outstanding and unvested Stock Options and RSUs is contingent upon the holder’s continued service through the date of each applicable vesting event. As of July 2, 2022, we had approximately 7.5 million shares of common stock available for future grants under the Plan.
As of July 2, 2022, the aggregate unamortized value of all outstanding equity-based compensation awards was approximately $31.5 million, which is expected to be recognized over a weighted average period of approximately 2.6 years.
The following tables summarizes our Stock Option activity under the Plan during the nine months ended (in thousands, except per share amounts):
Includes 550,736 stock options that were subject to the Company’s achievement of the fiscal 2021 net income target which was deemed to have been met during the nine months ended July 2, 2022.
Restricted Stock Units
The following table summarizes our RSU activity under the Plan during the nine months ended (in thousands, except per share amounts):
During the three and nine months ended July 2, 2022, equity-based compensation expense was $2.9 million and $8.5 million, respectively, and includes Company related payroll tax expense. During the three and nine months ended July 3, 2021, equity-based compensation expense was $6.5 million and $20.6 million, respectively, and includes $0.4 million and $11.7 million associated with the vesting of performance-based equity units as a result of the Company’s IPO, respectively. These costs are reported in selling, general and administrative expenses (“SG&A”) in our condensed consolidated statements of operations.
The entire disclosure for share-based payment arrangement.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef